NTLA FY2027 EPS Increased by Brookline Capital Management
Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) – Analysts at Brookline Capital Management upped their FY2027 earnings estimates for shares of Intellia Therapeutics in a note issued to investors on Thursday, February 27th. Brookline Capital Management analyst L. Cann now expects that the company will earn $22.48 per share for the year, up from their […]
Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) – Analysts at Brookline Capital Management upped their FY2027 earnings estimates for shares of Intellia Therapeutics in a note issued to investors on Thursday, February 27th. Brookline Capital Management analyst L. Cann now expects that the company will earn $22.48 per share for the year, up from their […]
